FDA 483 - Yiling Pharmaceutical Ltd. - October 11, 2024
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Yiling Pharmaceutical Ltd. in Shijiazhuang, Hebei, China, a manufacturer of human drugs, was cited for significant deficiencies during an FDA inspection. Observations included inadequate cleaning of non-dedicated equipment leading to potential cross-contamination, failure to test incoming components before use, and incomplete re-qualification of an active pharmaceutical ingredient supplier. These issues indicate a lack of control over manufacturing processes and material quality.
ID · 9d745478-ada0-449c-bae5-9687e10cb7c6